UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Myelodysplastic Syndromes

The New England journal of medicine, 2009-11, Vol.361 (19), p.1872-1885

2009

Volltextzugriff (PDF)

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

Blood, 2016-05, Vol.127 (20), p.2391-2405

2016

Volltextzugriff (PDF)

The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overview with emphasis on the myeloid neoplasms

Chemico-biological interactions, 2010-03, Vol.184 (1), p.16-20

Vardiman, James W.

2010

Volltextzugriff (PDF)

The 2008 World Health Organization Classification System for Myeloproliferative Neoplasms: Order Out of Chaos

Cancer, 2009-09, Vol.115 (17), p.3842-3847

2009

Volltextzugriff (PDF)

The classification of MDS: From FAB to WHO and beyond

Leukemia research, 2012-12, Vol.36 (12), p.1453-1458

Vardiman, James

2012

Volltextzugriff (PDF)

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Blood, 2009-07, Vol.114 (5), p.937-951

2009

Volltextzugriff (PDF)

RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia

Nature communications, 2018-03, Vol.9 (1), p.1163-16, Article 1163

2018

Volltextzugriff (PDF)

The World Health Organization (WHO) classification of the myeloid neoplasms

Blood, 2002-10, Vol.100 (7), p.2292-2302

2002

Volltextzugriff (PDF)

Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics

Nature reviews. Clinical oncology, 2009-11, Vol.6 (11), p.627-637

2009

Volltextzugriff (PDF)

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies

Blood, 2008-09, Vol.112 (5), p.1646-1654

2008

Volltextzugriff (PDF)

Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology

Archives of pathology & laboratory medicine (1976), 2017-10, Vol.141 (10), p.1342-1393

2017

Volltextzugriff (PDF)

Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study

Journal of clinical oncology, 2006-08, Vol.24 (24), p.3904-3911

2006

Volltextzugriff (PDF)

A subset of Rosai-Dorfman disease exhibits features of IgG4-related disease

American journal of clinical pathology, 2013-05, Vol.139 (5), p.622-632

2013

Volltextzugriff (PDF)

Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis

Journal of clinical oncology, 2009-09, Vol.27 (27), p.4563-4569

2009

Volltextzugriff (PDF)

Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice

Blood, 2016-01, Vol.127 (3), p.310-313

2016

Volltextzugriff (PDF)

Chronic Myelogenous Leukemia, BCR-ABL1

American journal of clinical pathology, 2009-08, Vol.132 (2), p.250-260

VARDIMAN, James W

2009

Volltextzugriff (PDF)

Dose Intensification of Daunorubicin and Cytarabine During Treatment of Adult Acute Lymphoblastic Leukemia: Results of Cancer and Leukemia Group B Study 19802

Cancer, 2013-01, Vol.119 (1), p.90-98

2013

Volltextzugriff (PDF)

World health organization classification, evaluation, and genetics of the myeloproliferative neoplasm variants

Hematology, 2011, Vol.2011 (1), p.250-256

2011

Volltextzugriff (PDF)

Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study

Journal of clinical oncology, 2005-08, Vol.23 (24), p.5705-5717

2005

Volltextzugriff (PDF)

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series

Blood, 2003-07, Vol.102 (1), p.43-52

2003

Volltextzugriff (PDF)

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

Blood, 2010-09, Vol.116 (9), p.1413-1421

2010

Volltextzugriff (PDF)

Overexpression of the ETS-Related Gene, ERG, Predicts a Worse Outcome in Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9234-9242

2005

Volltextzugriff (PDF)

1 – 25 von 223

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(182)

Publikationsform

Artikel
(219)
Buchkapitel
(4)

Sprache

Englisch
(223)

Erscheinungsjahr

n.n

Thema

Humans
(158)
Science & Technology
(128)
Life Sciences & Biomedicine
(123)
Male
(89)
Female
(86)
Adult
(77)
Middle Aged
(77)
Biological And Medical Sciences
(76)
Medical Sciences
(76)
Aged
(63)
Hematologic And Hematopoietic Diseases
(62)
Hematology
(62)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(54)
Oncology
(44)
Prognosis
(31)
Bone Marrow - Pathology
(30)
Karyotyping
(30)
Adolescent
(26)
Chromosome Aberrations
(23)
Acute Disease
(22)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Myelodysplastic Syndromes

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia

The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: An overview with emphasis on the myeloid neoplasms

The 2008 World Health Organization Classification System for Myeloproliferative Neoplasms: Order Out of Chaos

The classification of MDS: From FAB to WHO and beyond

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

RNA cytosine methylation and methyltransferases mediate chromatin organization and 5-azacytidine response and resistance in leukaemia

The World Health Organization (WHO) classification of the myeloid neoplasms

Myeloproliferative neoplasms: contemporary diagnosis using histology and genetics

What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies

Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel

Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology

Adverse Prognostic Significance of KIT Mutations in Adult Acute Myeloid Leukemia With inv(16) and t(8;21): A Cancer and Leukemia Group B Study

A subset of Rosai-Dorfman disease exhibits features of IgG4-related disease

Pomalidomide Is Active in the Treatment of Anemia Associated With Myelofibrosis

Brca1 deficiency causes bone marrow failure and spontaneous hematologic malignancies in mice

Chronic Myelogenous Leukemia, BCR-ABL1

Dose Intensification of Daunorubicin and Cytarabine During Treatment of Adult Acute Lymphoblastic Leukemia: Results of Cancer and Leukemia Group B Study 19802

World health organization classification, evaluation, and genetics of the myeloproliferative neoplasm variants

Prognostic Factors and Outcome of Core Binding Factor Acute Myeloid Leukemia Patients With t(8;21) Differ From Those of Patients With inv(16): A Cancer and Leukemia Group B Study

Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study

Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series

Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT)

P-glycoprotein inhibition using valspodar (PSC-833) does not improve outcomes for patients younger than age 60 years with newly diagnosed acute myeloid leukemia: Cancer and Leukemia Group B study 19808

Overexpression of the ETS-Related Gene, ERG, Predicts a Worse Outcome in Acute Myeloid Leukemia With Normal Karyotype: A Cancer and Leukemia Group B Study

Suchergebnisse filtern